
Marco Del Buono
@marcodelbuono3
MD, Cardiologist, PhD, Fondazione Policlinico Gemelli, Rome, 🇮🇹
Former Research Fellow at VCU 🇺🇸
ID: 1124684985678614528
04-05-2019 14:39:31
534 Tweet
1,1K Followers
777 Following

Excellent overview of clinical trials (completed and ongoing) of anti-inflammatories in cardiovascular disease ahajournals.org/doi/abs/10.116… ATVB: An AHA Journal





QT interval matters in Takotsubo: Prolonged QT = higher risk of all-cause death and/or arrhythmias. jacc.org/doi/10.1016/j.… Paula Rodriguez Miguelez Marco Del Buono Francesco Moroni, MD Jordana Kron Benjamin Van Tassell AntonioAbbate VCU Health Pauley Heart Center VCU Internal Medicine Department UVA CVRC UVA Cardio UVA Medicine


IL-1 Blockade with Anakinra: A Game-Changer for STEMI Patients Across CAD Complexity pubmed.ncbi.nlm.nih.gov/39531530 AntonioAbbate MartinDenicolai Matteo Morello, MD Michele Golino Giuliana Corna MD Marco Del Buono Carla Agatiello Benjamin Van Tassell VCU Health Pauley Heart Center UVA CVRC UVA Cardio #Cardiology


Rare but dangerous!!! Marco Del Buono giulia_lavecchia Tommaso Sanna Francesco Moroni, MD Aldo Bonaventura Alessandra Vecchié UVA Cardio UVA CVRC rdcu.be/d5XAE


Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysis pubmed.ncbi.nlm.nih.gov/39939545/ Thanks Beth and Gad for leading this effort - a good start to support the way further UVA CVRC UVA Cardio Benjamin Van Tassell

Optimizing Digoxin Use in Critically Ill Patients: Lessons from a Retrospective Study pubmed.ncbi.nlm.nih.gov/39812525 Marco Del Buono simone filomia #Digoxin #AtrialFibrillation #CriticalCare #Pharmacology #Cardiology


We explored the detection rate of late gadolinium enhancement in Takotsubo syndrome. Check out our study to learn more! Marta Figueiral, MD Matteo Castrichini, MD Naveen Pereira Luca Saba AntonioAbbate Michele Golino sciencedirect.com/science/articl…


Indobufen: A Game-Changer for Aspirin Hypersensitivity or Just a Niche Alternative? pubmed.ncbi.nlm.nih.gov/40053571 Marco Del Buono simone filomia #Cardiology #AspirinHypersensitivity #Indobufen #Antiplatelet #Pharmacology



Semaglutide: more than weight loss? Our new meta-analysis in EJPC Editor-in-Chief (~49,000 pts) shows a 17% reduction in new-onset AFib. Great collaboration! Link: doi.org/10.1093/eurjpc… Arturo Cesaro AntonioAbbate


Very cool .... but it should say "Takotsubo syndrome detected by Smartwatch" Austin Hogwood, PhD Paula Rodriguez Miguelez Michele Golino Marco Del Buono Cardiac Injury Detected by Smartwatch | New England Journal of Medicine nejm.org/doi/full/10.10…

Ivabradine Reduces Symptoms in POTS: Is Tachycardia the Culprit? pubmed.ncbi.nlm.nih.gov/40294227 AntonioAbbate #POTS #Ivabradine #HeartRate #AutonomicDisorders #CardiologyResearch


Case Report of Fulminant Eosinophilic Myo-pericarditis Related to Checkpoint Inhibitors Complicated by Acute Heart Failure and Cardiac Tamponade academic.oup.com/ehjcr/article/… Francesco Moroni, MD Yacub Betz UVA Cardio UVA CVRC UVA Medicine

Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants | Circulation ahajournals.org/doi/10.1161/CI… Important observation from Alessio Gasperetti, MD PhD Nisha Gilotra #cardioimmunology

Inflammation in coronary atherosclerosis: diagnosis and treatment heart.bmj.com/content/111/17… MASTERPIECE by Giovanni Occhipinti and international team including Salvatore Brugaletta Daniela Pedicino Marco Del Buono Ramona Vinci Giuseppe Biondi-Zoccai Manel Sabate, Dominick Angiolillo Giovanna Liuzzo
